5 pages/≈1375 words
Health, Medicine, Nursing
Inhibitors of 17β-hydroxysteroid dehydrogenase type 3 in the treatment of prostate cancer (Essay Sample)
Websites should not be used (loss of 10%). Marks will be deducted (minimum of 20% in addition to other deductions) for not following the above guidelines. You should note that the reports must be submitted via Turnit-in on Blackboard and Turnit-in will conduct extensive checks for plagiarism. Your assignment will involve the preparation of a 5 page review/report excluding figures, pictures and references (1.5 spacing, 1 inch margins all round and using Arial font size 11) on a relevant topic. (iii). Inhibitors of 17β-hydroxysteroid dehydrogenase type 3 in the treatment of prostate cancer. Websites should not be used (loss of 10%). Marks will be deducted (minimum of 20% in addition to other deductions) for not following the above guidelines. You should note that the reports must be submitted via Turnit-in on Blackboard and Turnit-in will conduct extensive checks for plagiarism. You will be able to get feedback from Dr Le Gresley after the Christmas break. ANY SIGN OF PLAGIARISM WILL BE DEALT WITH IN A SEVERE MANNER AND YOU WILL LOSE ALL MARKS. NO excuses will be accepted for the late submission of reports, Marking Scheme: Contents (10%) Abstract (summarising the report on 1 side of A4) (10%) Overall presentation (20%) References cited in an appropriate manner (10%) Scientific content relevant to MEDICINAL CHEMISTRY (50%) Total 100% source..
INHIBITORS OF 17Î’-HYDROXYSTEROID DEHYDROGENASE TYPE 3 IN THE TREATMENT OF PROSTATE CANCER Name Grade Course: Tutor`s Name: (September 30, 2011) Inhibitors of 17Î²-hydroxysteroid dehydrogenase type 3 in the treatment of prostate cancer Abstract 17 ÃŸ-hydroxysteroid dehydrogenase (17ÃŸ-HSD) type 3 is an enzyme found in high amounts in the testes and plays a major role in biosynthesis of androgens such as testosterone hormone which is responsible for both internal and physical male characteristics. The role of 17ÃŸ-HSD type 3 in Prostate cancer treatment has widely been studied with emphasis on the inhibitors of the enzyme. In normal cells, 17ÃŸ-HSD type 3 enzymes have binding sites on androgen receptors on to which they bind and enhance transcription of genes that facilitate their multiplication. In cancer, the activity of 17ÃŸ-HSD type 3 has been observed to be much higher as compared to normal cells and gene transcription for the enzyme occurs in 15 minutes or less. Various studies show that inhibitors do exist that compete for the 17ÃŸ-HSD type 3 binding sites on the androgen receptors and others that block the enzymes from binding onto the androgen receptors, these have been broadly divided into two groups namely steroidal and non-steroidal inhibitors. By so doing the inhibitors alter the activity of 17ÃŸ-HSD type 3 hence reducing the amount of testosterone in blood and in the prostate. Many existing prostate cancer treatment modes including castration aim at lowering the levels of testosterone and following the fact that many inhibitors leading to the same effect exist, prostate cancer treatment can be enhanced through this manner. Introduction 17 ÃŸ-hydroxysteroid dehydrogenases (17ÃŸ-HSD) are enzymes found in humans and other animals such as rats; they are common in the testes, placenta and ovaries (Penning, 1996). The 17 ÃŸHSD exist as isoenzymes and in general are responsible for the biosynthesis of the male and female sex hormones testosterone and estrogen, they catalyze the last step in the formation of these hormones. The common isoforms of the 17-ÃŸHSD are namely type 1, type 2 , type 3 and type 4 and type 5, although other types up to type 15 exist. The type 3 17ÃŸ-HSD have been observed to be largely located in the testes prostate and seminal vesicles (Vicker, Sharland & Heaton et al, 2008). In the testes, the type 3 17ÃŸ-HSD plays an important role in synthesis of androgens by converting the 4-di-one substrate into testosterone. Given the significant role of the 17ÃŸ-HSD type 3 in biosynthesis of testosterone, there has been an increased interest in this particular type of 17ÃŸ-HSD with relation to treatment of prostate cancer because the androgen receptor has been observed to provide room for further growth and spread or prostate tumors (Narizhneva, Tararova & Ryabokon et al, 2009). Various researches show that inhibition of 17ÃŸ-HSD type 3 leads to production of low levels of androgens or none at all hence an effective anti-cancer mechanism. This paper will discuss of the inhibitors of 17ÃŸ-HSD type 3 especially in treatment of prostate cancer. Discussion 17ÃŸ-HSD type 3 is so crucial for the normal development of males such that any slight defects in the enzyme lead to various abnormalities such as pseudohermaphroditism which is a condition where the affected person exhibits dual sexual organs. The mechanism of such abnormalities has been explained as one that originates at the androgen receptors whereby the receptor activity is altered hence leading to a halt in development of male organs (Luu-The, BeÂ´langer & Labrie, 2008, p 209). This shows that the androgens (testosterone and dihydrotestosterone) are no longer synthesized hence an implication that the two hormones possibly share the same and...
Get the Whole Paper!
Not exactly what you need?
Do you need a custom essay? Order right now:
You Might Also Like Other Topics Related to plagiarism:
- Parkinson's Disease BIO360HONG_2011SpV1.2Description: Recent advances for rare genetic disease/disorder in humans or genetically engineered plants or animals for commercial use...3 pages/≈825 words | 4 Sources | MLA | Health, Medicine, Nursing | Research Paper |
- The Communication ProcessDescription: Communications and Media Essay: The Communication Process...1 page/≈275 words | 1 Source | APA | Communications & Media | Book Review |
- Accounting (Article Summary)Description: Business and Marketing Article: Accounting (Article Summary)...1 page/≈275 words | 1 Source | APA | Business & Marketing | Article |